생약추출물을 이용한 키 성장 기능성 식품 개발

The Development of Functional Food with Plant Extracts for Enhancing Growth Rate

  • 발행 : 2004.09.01

초록

다양한 종류의 생약재들이 동물과 인간의 성장률을 증진시키는 활성을 가지고 있는 것으로 보고되고 있다. 선정된 식물의 성장증진 효과를 확인하기 위해 실험동물로서 물고기와 돼지를 이용하였다. 물고기 실험에서 오카피 추출물과 인진쑥 추출물이 가장 효과적인 것으로 나타났다. 그리고 이들 오가피와 인진쑥 추출물을 돼지에 먹여본 결과 평균 일일 증체율이 대조군에 비해 7.06% 증가하였다. ㅇ 결과를 검증하기위해 혈액 내 분비된 성장호르몬(GH)과 Insulin-like growth factor-1(IGF-1)의 양을 측정하였다. 오가피와 인진쑥 추출물을 먹인 돼지는 대조군에 비해 혈액 내로 분비된 GH와 IGF-1의 양이 훨씬 더 많았다. 인간에서 성장증진 효과를 알아보기 위해 본 연구자들은 오가피와 인진쑥 추출물을 혼합하여 쌀에 코팅한 $키우미^{TM}$($Kiwoomi^{TM}$)를 제조하였다. $키우미^{TM}$를 초등학생들에게 먹였을 때 키 성장에 효과적인 것을 확인하였다. $키우미^{TM}$를 먹인 아이들이 먹이지 않은 아이들보다 더 많이 성장하였다(약 2.14배). 결과적으로 이 기능성 쌀($Kiwoomi^{TM}$)이 다른 부작용 없이 아이들의 성장에 도움을 주는 것으로 판단된다.

It has been reported that various kinds of chinese herbs have an activity of promote growth rate in both animals and human. To investigate the growth promoting effect of the selected plants, fish and pigs were used as experimental animals. In fish, Eleutherococcus senticosus extract and Artemisia capillasis extract were found to be most effective. And these plant extracts were given to pigs. The result showed that plant extracts-fed pigs were significantly increased their body weight gain at 7.06% of average daily gain, as compared to control. The verify this results, secreted growth hormone (GH)levels and insulin-like growth factor-1 (ICF-1) levels into blood were measured. This result indicated that GH and IGF-1 levels in the blood in plant extracts-fed pigs were higher that those of control. To confirm growth promotion effect on human, we manufactured the mixture of these plant extracts, and coated this mixture onto rice, named as $Kiwoomi^{TM}$. When we administered $Kiwoomi^{TM}$ to elementary students, it was found to be effective in growth promotion. This result showed that $Kiwoomi^{TM}$-treated elementary students significantly increased their growth rate (about 2.14 times), as compared to untreated children. Taken together, it is suggested that this functional rice ($Kiwoomi^{TM}$) might be helpful for growing children without any side effects.

키워드

참고문헌

  1. Klaus, G., Jux, C., Fernandez, P., Rodriguez, J., Himmele, R. and Mehls, O.: Suppression of growth plate chondrocyte proliferation by conticosteriods. Pediatr Nephrol., 14, 612-615 (2000) https://doi.org/10.1007/s004670000344
  2. Choi, CS., Kim, J.S., Lee, CW., and Park, J.S.: Effect of Plant Extract(YGF) on inducing IGF-1 Secretion. Korean J. Biotechnol. Bioeng., 17(2), 203-206 (2002)
  3. Arsenijevic, Y., Weiss, S., Schneider, B., and Aebischer, P.: Insulin-like growth factor-I is necessary for neural stem cell proliferation and demonstrates distinct actions of epidermal growth factor and fibroblast growth factor-2. J. Neurosei., 21, 7194-7202 (2001)
  4. Cappola, A.R., Bandeen-Roche, K., Wand, G.S., Volpato, S. and Fred, L.P.: Association of IGF-1 levels with muscle strength and mobility in older women. J. Clin. Endoerinol. Metab., 86, 4139-4146 (2001) https://doi.org/10.1210/jc.86.9.4139
  5. Shiotarni, A., Fukumura, M., Maeda, M., Hou, Z., Inoue, M., Kanamori, T., Komaba, S., Washizawa, K., Fujukawa, S., Yamanodo, T., Kadono, C, Watabe, K., Fukuba, H., Saito, K., Sakai, Y., Nagai, Y., Kanzaki, J. and Hasegawa, M.: Skeletal muscle regeneration after insulin-like growth factor I gene transfer by recombinant Sendai virus vector. Gene Ther., 8, 1043-1050 (2001) https://doi.org/10.1038/sj.gt.3301486
  6. Singleton, J.R. and Feldman, E.L.: Insulin-like growth factorI in muscle metabolism and myotherapies. Neurobiol. Dis., 8, 541-554 (2001) https://doi.org/10.1006/nbdi.2001.0416
  7. Woods, K.A, Camacho-Hubner, C, Savage, M.O. and Clark, AJ.: Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. New Engl. J. Med., 335, 1363-1367 (1996) https://doi.org/10.1056/NEJM199610313351805
  8. Woods, K.A., Camacho-Hubner, C, Bergman, T.N., Barter, D., Clark, A.J. and Sabage, M.O.: Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion. J. Clin. Endocrinol. Metab., 85, 1407-1411 (2000) https://doi.org/10.1210/jc.85.4.1407
  9. Blum, W.E, Albertsson-Wikland, K., Rosberg, S. and Ranke, M.B.: Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J. Clin. Endoerinol. Metab., 76, 1610- 1616 (1993) https://doi.org/10.1210/jc.76.6.1610
  10. Cai, K., Ya, K., Lin, S., Yang, Z., Li, x., Xie, H., Qing, T. and Gao L.: Poly(-lactic acid) surfaces modified by silk fibroin: effects on the culture of osteoblast in vitro. Biomaterials, 23, 1153-1160 (2002) https://doi.org/10.1016/S0142-9612(01)00230-7
  11. Nakao, Y., Otani, H., Yamamura, T., Hattori, R., Osako, M. and Imamura, H.: Insulin-like growth factor I prevents neuronal cell and paraplegia in the rabbit model of spinal cord ischemia. J. Thome. Cardiovase. Surg., 122, 136-143 (2001) https://doi.org/10.1067/mtc.2001.114101